Cardiovascular events in patients with COPD after long-acting bronchodilator initiation

Background Real-world evidence concerning the cardiovascular (CV) risk of umeclidinium (UMEC) monotherapy or UMEC/vilanterol (VI) is scarce. This real-world study investigated CV risk in new users of UMEC or UMEC/VI versus new users of tiotropium (TIO) in patients with chronic obstructive pulmonary...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Dave Singh, Ana R. Sousa, David E. Newby, Michele Jonsson Funk, Miguel Roman-Rodriguez, Peter Kardos, Gema Requena, Alison Donald, David Slade, Chris Compton
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	European Respiratory Society 2026-06-01
Ráidu:	ERJ Open Research
Liŋkkat:	https://doi.org/10.1183/23120541.01691-2025
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!